Cargando…
A Multi-Site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens
Rifampicin (R) and isoniazid (H) are key first-line anti-tuberculosis drugs. Failure to detect resistance to these two drugs early results in treatment failure and poor clinical outcomes. The study purpose was to validate the use of the GenoType MTBDRplus line probe assay (LPA) to detect resistance...
Autores principales: | Raizada, Neeraj, Sachdeva, K. S., Chauhan, D. S., Malhotra, Bharti, Reddy, Kishore, Dave, P. V., Mundade, Yamuna, Patel, Pranav, Ramachandran, Ranjani, Das, Ram, Solanki, Rajesh, Wares, Douglas Fraser, Sahu, Suvanand, O'Brien, Rick, Paramasivan, C. N., Dewan, Puneet K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929364/ https://www.ncbi.nlm.nih.gov/pubmed/24586360 http://dx.doi.org/10.1371/journal.pone.0088626 |
Ejemplares similares
-
Is One Sputum Specimen as Good as Two during Follow-Up Cultures for Monitoring Multi Drug Resistant Tuberculosis Patients in India?
por: Nagaraja, Sharath Burugina, et al.
Publicado: (2012) -
HIV Seroprevalence among Tuberculosis Patients in India, 2006–2007
por: Raizada, Neeraj, et al.
Publicado: (2008) -
Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009) -
The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015) -
Risk Factors for Treatment Default among Re-Treatment Tuberculosis Patients in India, 2006
por: Jha, Ugra Mohan, et al.
Publicado: (2010)